Online
Browse
Drugs
Starred Drugs
Categories
Pathways
Drug Reactions
Drug Classification
Drug Targets
Pharmaco-genomics
Pharmaco-metabolomics
Pharmaco-transcriptomics
Pharmaco-proteomics
COVID-19
Overview
Vaccine Side Effects
Search
Chemical Structure
Molecular Weight
Drug & Food Interactions
Target Sequences
Pharmaco-omics
Advanced Search
MS Search
MS/MS Search
GC/MS Search
1D NMR Search
2D NMR Search
Interaction Checker
Downloads
Solutions
Products
Commercial Research
Drug Datasets
Academic Research
Drug Datasets
Clinical API
Use Cases
Drug Discovery & Repurposing
In Silico
Testing
Precision Medicine
Telehealth
Electronic Medical Records
Resources
Books & Webinars
About
Help Center
Citing DrugBank
DrugBank Online FAQs
Searching DrugBank
Other Databases
Data Sources
About
About DrugBank Online
DrugBank in Research
Statistics
Blog
Wishart Research Group
Contact Us
Drugs
Targets
Pathways
Indications
Next Up in the Quality Data Series: Cross-Referencing Related Data
Read Blog!
Stage III Cutaneous Melanoma AJCC v7
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB00041
Aldesleukin
1
Recruiting
1
DB00531
Cyclophosphamide
1
Recruiting
1
DB08912
Dabrafenib
1
Active Not Recruiting
1
DB08912
Dabrafenib
1
Terminated
1
DB01073
Fludarabine
1
Recruiting
1
DB01611
Hydroxychloroquine
1
Active Not Recruiting
1
DB09053
Ibrutinib
1
Recruiting
1
DB06186
Ipilimumab
1
Terminated
2
DB16828
MK-2206
1
Active Not Recruiting
1
DB09035
Nivolumab
1
Terminated
2
DB06306
Onalespib
1
Active Not Recruiting
1
DB09037
Pembrolizumab
1
Recruiting
1
DB00740
Riluzole
1
Active Not Recruiting
1
DB06176
Romidepsin
1
Active Not Recruiting
1
DB00398
Sorafenib
1
Active Not Recruiting
1
DB08911
Trametinib
1
Active Not Recruiting
1
DB08911
Trametinib
1
Terminated
1
DB00041
Aldesleukin
1 / 2
Active Not Recruiting
1
DB00531
Cyclophosphamide
1 / 2
Active Not Recruiting
1
DB01073
Fludarabine
1 / 2
Active Not Recruiting
1
DB05996
Glembatumumab vedotin
1 / 2
Withdrawn
1
DB06186
Ipilimumab
1 / 2
Active Not Recruiting
1
DB06186
Ipilimumab
1 / 2
Withdrawn
1
DB09035
Nivolumab
1 / 2
Active Not Recruiting
1
DB09035
Nivolumab
1 / 2
Withdrawn
1
DB09037
Pembrolizumab
1 / 2
Active Not Recruiting
1
DB08885
Aflibercept
2
Completed
1
DB00041
Aldesleukin
2
Completed
2
DB11967
Binimetinib
2
Active Not Recruiting
1
DB11059
Carboxymethylcellulose
2
Completed
1
DB00531
Cyclophosphamide
2
Completed
1
DB08912
Dabrafenib
2
Active Not Recruiting
2
DB11718
Encorafenib
2
Active Not Recruiting
1
DB01073
Fludarabine
2
Completed
1
DB06186
Ipilimumab
2
Active Not Recruiting
2
DB00123
Lysine
2
Completed
1
DB15994
Methane
2
Active Not Recruiting
1
DB09035
Nivolumab
2
Active Not Recruiting
2
DB09037
Pembrolizumab
2
Active Not Recruiting
1
DB15185
Rasdegafusp alfa
2
Completed
1
DB00020
Sargramostim
2
Active Not Recruiting
1
DB13896
Talimogene laherparepvec
2
Active Not Recruiting
1
DB08911
Trametinib
2
Active Not Recruiting
2
DB06186
Ipilimumab
2 / 3
Recruiting
1
DB09035
Nivolumab
2 / 3
Recruiting
1
DB00020
Sargramostim
2 / 3
Recruiting
1
DB11105
Benzalkonium
3
Active Not Recruiting
1
DB08912
Dabrafenib
3
Active Not Recruiting
1
DB05258
Interferon alfa
3
Active Not Recruiting
1
DB00105
Interferon alfa-2b
3
Active Not Recruiting
1
DB06186
Ipilimumab
3
Active Not Recruiting
2
DB15994
Methane
3
Active Not Recruiting
1
DB09035
Nivolumab
3
Active Not Recruiting
1
DB09037
Pembrolizumab
3
Active Not Recruiting
1
DB08911
Trametinib
3
Active Not Recruiting
1